Company profile for Pathios Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Pathios Therapeutics is an early-stage drug discovery company that was established in 2017 by a team of experienced pharmaceutical industry professionals and biotech entrepreneurs. Based in Oxford, UK, the company is founded upon a deep understanding of the biology of acid-sensing GPCRs in Th17 cells and tumour-associated macrophages (TAMs). We are currently engaged in a fully-enabled drug discovery program to identify novel s...
Pathios Therapeutics is an early-stage drug discovery company that was established in 2017 by a team of experienced pharmaceutical industry professionals and biotech entrepreneurs. Based in Oxford, UK, the company is founded upon a deep understanding of the biology of acid-sensing GPCRs in Th17 cells and tumour-associated macrophages (TAMs). We are currently engaged in a fully-enabled drug discovery program to identify novel small-molecule modulators of GPR65 with expected utility in a range of autoimmune conditions as well as in certain cancers.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
United Kingdom
Address
Address
Clarendon Business Centre, 57 Woodstock Road, Oxford, OX2 6HJ
Telephone
Telephone
+44 1865 292 039
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/pathios-therapeutics-appoints-jon-wigginton-md-as-non-executive-director-302564962.html

PR NEWSWIRE
24 Sep 2025

https://www.contractpharma.com/breaking-news/pathios-therapeutics-names-sumeet-ambarkhane-as-chief-medical-officer/

CONTRACTPHARMA
24 Mar 2025

https://www.prnewswire.com/news-releases/pathios-therapeutics-appoints-sumeet-ambarkhane-md-as-chief-medical-officer-302408287.html

PR NEWSWIRE
24 Mar 2025

https://www.prnewswire.com/news-releases/pathios-therapeutics-announces-dosing-of-first-patient-in-phase-12-clinical-study-of-gpr65-inhibitor-ptt-4256-in-patients-with-advanced-solid-cancers-302310915.html

PR NEWSWIRE
20 Nov 2024

https://www.prnewswire.com/news-releases/pathios-therapeutics-appoints-paul-g-higham-as-chief-executive-officer-as-company-prepares-to-enter-the-clinic-302191187.html

PR NEWSWIRE
09 Jul 2024

https://endpts.com/pathios-rakes-in-25m-to-help-start-trials-for-gpr65-inhibitor/

Reynald Castañeda ENDPTS
18 Apr 2024

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty